A German study on patients who underwent FDG-PET/CT scans for neoplastic disease found that "the combination of a calcified plaque sum greater than 15 and a mean TBR of greater than 1.7 identified patients at highest risk for a future vascular event." The finding suggests that patients undergoing PET/CT tests for cancer diagnosis or staging could also know their atherogenic risk, the researchers said.

Related Summaries